CRCbioscreen Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

CRCbioscreen General Information

Description

Developer of a cancer screening test designed to prevent death from colorectal cancer. The company is developing a novel, multi-target Faecal Immunochemical Test (mt FIT) to replace classical FIT testing by incorporating novel biomarkers, providing healthcare professionals with diagnostic tests for early detection of colorectal cancer.

Contact Information

Website
www.crcbioscreen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Health & Innovation District (Hid)
  • Plesmanlaan 125
  • 1066 CX Amsterdam
  • Netherlands
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Health & Innovation District (Hid)
  • Plesmanlaan 125
  • 1066 CX Amsterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CRCbioscreen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 01-Sep-2024 Completed Clinical Trials - General
3. Accelerator/Incubator 01-Jul-2021 Completed Clinical Trials - General
2. Seed Round 17-Mar-2021 $1.05M $1.05M Completed Clinical Trials - General
1. Spin-Off 01-Jan-2021 Completed Clinical Trials - General
To view CRCbioscreen’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CRCbioscreen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CRCbioscreen Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amsterdam UMC Ventures Holding Venture Capital Minority
Health ~ Holland Government
Human Plus Fund Corporation Minority
The Mark Foundation for Cancer Research Venture Capital Minority
The Netherlands Cancer Institute Corporation
To view CRCbioscreen’s complete investors history, request access »

Ready to get started?

Request a free trial

CRCbioscreen FAQs

  • When was CRCbioscreen founded?

    CRCbioscreen was founded in 2021.

  • Where is CRCbioscreen headquartered?

    CRCbioscreen is headquartered in Amsterdam, Netherlands.

  • What is the size of CRCbioscreen?

    CRCbioscreen has 4 total employees.

  • What industry is CRCbioscreen in?

    CRCbioscreen’s primary industry is Diagnostic Equipment.

  • Is CRCbioscreen a private or public company?

    CRCbioscreen is a Private company.

  • What is CRCbioscreen’s current revenue?

    The current revenue for CRCbioscreen is .

  • How much funding has CRCbioscreen raised over time?

    CRCbioscreen has raised $1.05M.

  • Who are CRCbioscreen’s investors?

    Amsterdam UMC Ventures Holding, Health ~ Holland, Human Plus Fund, The Mark Foundation for Cancer Research, and The Netherlands Cancer Institute have invested in CRCbioscreen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process